The seventh edition of the Indian Pharmacopoeia (IP 2014) is published by the Indian Pharmacopoeia Commission (IPC) on behalf of the Government of India, Ministry of Health & Family Welfare. The Indian Pharmacopoeia (IP) is published in fulfilment of the requirements of the Drugs and Cosmetics Act, 1940 and Rules thereunder. It prescribes the standards for drugs produced and/or marketed in India and thus contributes in the control and assurance of the quality of the medicines. The standards of this pharmacopoeia are authoritative and legally enforceable. It intends to help in the licensing of manufacturing units, inspection and distribution of medicines.
IP is published in continuing pursuit of the mission of IPC to improve the health of the people through ensuring the quality, safety and efficacy of medicines. The Commission has been receiving significant inputs from regulatory, industrial houses, academic institutions, national laboratories, individual scientists and others. Publication of IP at regular and shorter intervals is one of the main mandates of the Commission.
The seventh edition of Indian Pharmacopoeia 2014 is published in accordance with the principles and design plan decided by the Scientific Body of the IPC. To establish transparency in setting standards for this edition, the contents of new monographs, revised appendices and other informations have been publicized on the website of the IPC, besides following conventional approach of obtaining comments. The feedback and inputs were reviewed by the relevant Expert Committee to ensure the feasibility and practicability of the standards and methods revised. The principle of “openness, justice and fairness” is kept in mind during compiling and editing the contents of this edition.
The Indian Pharmacopoeia 2014 is presented in four volumes. The scope of the Pharmacopoeia has been extended to include products of biotechnology, indigenous herbs and herbal products, veterinary vaccines and additional antiretroviral drugs and formulations, inclusive of commonly used fixed-dose combinations. Standards for new drugs and drugs used under National Health Programmes are added and the drugs as well as their formulations not in use now a days are omitted from this edition.
The IP 2014 incorporates 2548 monographs of drugs out of which 577 are new monographs consisting of APIs, excipients, dosage forms, antibiotic monographs, insulin products and herbal products etc. 19 New Radiopharmaceutical Monographs and 1 General chapter is first time being included in this edition. It is hoped that this edition would play a significant role in improving the quality of medicines which in turn promote public health and accelerate the growth and development of Pharma Sector.
Press Release of IP 2014
News & Highlights
- PT schedule-2023
- Applications are invited for the post of Jr. Materiovigilance Associate at Indian Pharmacopoeia Commission (IPC), an Autonomous organization under the Ministry of Health & Family Welfare, Ghaziabad
- DRAFT AMENDMENTS _vaccines and immunosera for human use_17.03.2023
- Application are invited for the 25th Skill Development Programme On Pharmacovigilance for Medical Products
- Link for Opening of Technical Bids on 03.03.2023, 11:00 Hrs. against Impurity Tender No. IPC/5535/2022-23- Reg. Hosted by Indian Pharmacopoeia Commission
- Press Release
- PT round 01, 2023 in Assay by HPLC in tablet formulation.
- Order Issued by National Medical Commission for Enrolment of Medical Colleges as Adverse Drug Reactions (ADR) Monitoring Centres Under PvPI
- Link for Pre-bid Meeting against Reference Substances IPC Tender No. IPC/5535/2022-23
- Corrigendum II of GeM tender for digitalization of Indian Pharmacopoeia - reg.
- Tender Document for Supply of “CANDIDATE MATERIAL FOR PREPARATION OF IP REFERENCE SUBSTANCES” at IPC, Ghaziabad
- Corrigendum I of GeM tender for digitalization of Indian Pharmacopoeia - reg.
- IPC Notices and Updates
- Pre-Bid Meeting for GeM Tender for Digitalization of Indian Pharmacopoeia
- Amendments in Rituximab and Rituximab Injection monographs in IP 2022
- Apply for GeM Tender for Digitalization of Indian Pharmacopoeia (IP) Last date: 11-02-2023 "
- Draft Amendments
- Microbiology General Chapters
- Draft amendments
- 15Th Foundation Day Celebration of Indian Pharmacopoeia Commission
- Cancellation notice for GeM tender for digitalization of Indian Pharmacopoeia
- Skill Development Progamme.
- Cancellation notice for GeM tender for digitalization of Indian Pharmacopoeia
- Indian Pharmacopoeia Commission launches 10 New IP Impurities Substance
- Applications are invited for filling up various posts through Deputation (Including Short Term Contract)
- Invitation of BIDs for Hiring of Security Manpower Agency for providing Security Personnel (i.e. Security Supervisor, Gunmen & Security Guards) in IPC, Sector-23, Raj Nagar, Ghaziabad-201002 (UP).
- Corrigendum II of GeM tender for digitalization of Indian Pharmacopoeia
- Invitation of BIDS for Procurement of Lab Furniture for New ALRC Building at Indian Pharmacopoeia Commission, Ghaziabad.
- CORRIGENDUM-I GEM Tender for Digitalization of Indian Pharmacopoeia Reg.
- CORRIGENDUM-I GEM Tender for Digitalization of Indian Pharmacopoeia Reg.
View All